Education and Outreach

$137,751U54FY2009CANIH

Emory University, Atlanta GA

Investigators

Linked publications & trials

Paper 33073266 Paper 33029594 Paper 30998482 Paper 30221254 Paper 30221253 Paper 29568818 Paper 29568817 Paper 29568673 Paper 28393153 Paper 28393152 Paper 28393151 Paper 28393145 Paper 28393144 Paper 28392890 Paper 28392889 Paper 28268850 Paper 28268818 Paper 28164175 Paper 28164174 Paper 28163980 Paper 28133638 Paper 28133637 Paper 28133627 Paper 28133502 Paper 28111639 Paper 28105382 Paper 27595138 Paper 27588027 Paper 27583310 Paper 27583309 Paper 27536740 Paper 27536739 Paper 27536420 Paper 27532065 Paper 27532064 Paper 27532063 Paper 27532062 Paper 27532061 Paper 27532060 Paper 27532059 Paper 27532058 Paper 27532057 Paper 27532026 Paper 27532016 Paper 27532012 Paper 27525167 Paper 27493999 Paper 27341302 Paper 27170860 Paper 27100344 Paper 26918848 Paper 26738195 Paper 26737857 Paper 26737772 Paper 26736365 Paper 26736237 Paper 26508443 Paper 26462248 Paper 26313540 Paper 26292334 Paper 26109056 Paper 25585410 Paper 25571589 Paper 25571472 Paper 25571173 Paper 25571169 Paper 25571059 Paper 25570358 Paper 25569930 Paper 25518043 Paper 25152701 Paper 25150838 Paper 24808220 Paper 24564364 Paper 24407308 Paper 24403290 Paper 24396518 Paper 24336693 Paper 24110765 Paper 24110361 Paper 24110238 Paper 24110179 Paper 24109770 Paper 24083057 Paper 23959844 Paper 23914967 Paper 23812946 Paper 23751374 Paper 23719266 Paper 23527547 Paper 23497380 Paper 23440717 Paper 23402593 Paper 23367436 Paper 23366904 Paper 23366422 Paper 23365541 Paper 23343408 Paper 23292656 Paper 23231990

Abstract

Summary This CCNE core for Education and Outreach has the following main functions: (1) to develop curricula on cancer nanotechnology for an emerging generation of young investigators in the physical sciences, bioengineering, medical schools, schools of public health and nursing, and PhD trainees in cancer biology;to provide new research protocols and procedures for other laboratories via website and CDROM publications to the world cancer research community;(3) to provide continuing medical education (CME) opportunities for US clinicians (both oncologists and oncology nurses) engaged in multidisciplinary cancer care who will see nanotechnology emerge in the care of their cancer patients;and (4) to become a leader with our neighbors and partners at the Centers for Disease Control and the American Cancer Society in patient, family, and US media nanotechnology educational materials written at the lay level. These efforts are designed to reach a broad spectrum of people who could benefit from cancer nanotechnology, including the cancer research community, clinical oncology care community, undergraduates in engineering, medical students, graduate students, and the US news media.

View original record on NIH RePORTER →